Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCH: Methylprednisolone with EVT for Large Ischemic Stroke
NCT06870448Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Apr 2025
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone sodium succinate in ischemic stroke, sponsored by Sun Yat-sen Memorial Hospital. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06870448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870448.